October fall: Investors lose Rs 37L cr

After gaining over Rs 87 lakh crore in the first half of the financial year, stock market investors have seen their wealth erode by 43% or Rs 37 lakh crore in October – the worst in a single month.

Before this, the worst-ever monthly market cap loss was in March 2020, when the panic over the Covid pandemic saw investors lose as much as Rs 33.4 lakh crore.

The Sensex and the Nifty have fallen 5.8% and 6.3%, respectively, this month, while the broader market indices have seen a sharper cut of up to 9%. At the end of Friday, the market capitalisation of BSE-listed companies stood at Rs 437 lakh crore ($5.2 trillion).

The persistent selling saw the Sensex close below the 80,000-point mark for the first time in over two months. The 30-stock index fell 0.8% to 79,402.29 points on Friday, and the Nifty closed 0.9% lower at 24,180.80.

“The correction was overdue because the fundamentals are not supporting. The April-June earnings were mixed. Now, the September quarter has also not (been) great so far,” said Ambareesh Baliga, an independent market analyst.

Foreign portfolio investors (FPIs) have led the sell-off by dumping stocks worth $9.5 billion (Rs 79,363 crore) so far in October. On the other hand, domestic institutional investors (DIIs) have bought Rs 92,931 crore. Even on Friday, FPIs continued with their selling spree. They sold shares of Rs 3,036 crore, while DIIs were net buyers of Rs 4,159 crore, according to provisional data from the exchanges. This means that despite DIIs’ buying to the tune of almost Rs 1 lakh crore, the market has been falling consistently.

Elara Capital said that while the global fund flow into India has been coming down sharply, China saw fifth consecutive week of inflows, though at a slower pace.

The sell-off began late last month when FPIs started pulling money out of India and other emerging markets to increase exposure to China after it announced stimulus measures to revive its economy. 

The sentiment took a further hit this month due to weak earnings performance by domestic companies for the September quarter.

Baliga pointed out that it was retail money that had been driving the market so far.

 » Read More

Related Articles

8th Pay Commission: Central govt to merge pay scales for Level 1-6 employees? Here’s what the new proposal says

8th Pay Commission: The National Council of Joint Consultative Machinery (JCM) Staff Side has submitted its recommendations for the Terms of Reference (ToR) for the 8th Central Pay Commission (CPC), advocating significant changes in pay structure, allowances and benefits for government employees. Among the key points of ToR is the proposal for merger of certain

Bharti Airtel Q3 Results: Profit surges 505.24% to Rs 14,781.20 crore, ARPU at Rs 245

Bharti Airtel on Thursday posted a profit of Rs 14,781.20 crore during the third quarter of FY25, reporting a growth of 505.24 per cent in comparison to Rs 2442.20 crore during the corresponding quarter of FY24. The telecom major recorded Q3 revenue from operations at Rs 45,129.30 crore, up 19.08 per cent as against Rs

JB Pharma is riding the CDMO Opportunity. Jefferies reiterates buy…

Jefferies has maintained a Buy on JB Pharma with a revised target price of Rs 2,310. The stock currently trades at Rs 1,714/share implying an 34% upside. This new target price is just a shade lower than the previous target price of Rs 2,340. According to Jefferies, an international brokerage house, the growth drivers are

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Stay Connected

0FansLike
0FollowersFollow
0SubscribersSubscribe
- Advertisement -

Latest Articles

8th Pay Commission: Central govt to merge pay scales for Level 1-6 employees? Here’s what the new proposal says

8th Pay Commission: The National Council of Joint Consultative Machinery (JCM) Staff Side has submitted its recommendations for the Terms of Reference (ToR) for the 8th Central Pay Commission (CPC), advocating significant changes in pay structure, allowances and benefits for government employees. Among the key points of ToR is the proposal for merger of certain

Bharti Airtel Q3 Results: Profit surges 505.24% to Rs 14,781.20 crore, ARPU at Rs 245

Bharti Airtel on Thursday posted a profit of Rs 14,781.20 crore during the third quarter of FY25, reporting a growth of 505.24 per cent in comparison to Rs 2442.20 crore during the corresponding quarter of FY24. The telecom major recorded Q3 revenue from operations at Rs 45,129.30 crore, up 19.08 per cent as against Rs

JB Pharma is riding the CDMO Opportunity. Jefferies reiterates buy…

Jefferies has maintained a Buy on JB Pharma with a revised target price of Rs 2,310. The stock currently trades at Rs 1,714/share implying an 34% upside. This new target price is just a shade lower than the previous target price of Rs 2,340. According to Jefferies, an international brokerage house, the growth drivers are

Two banking stocks to watch ahead of the RBI Policy

By Kiran Jani Bank Nifty reached its all-time high of 54,467 in September 2024. Following this peak, the index experienced a correction, dipping to 47,844 in January 2025—a decline of 7.29%. Despite this pullback, Kotak Bank and ICICI Bank showed relative resilience, delivering returns of 1.61% and -4.20%, respectively, during the same period. Source: Investing.com

New Tax Regime: These deductions, exemptions still available for you

The Indian government introduced a new tax regime in 2020, offering lower tax rates while removing several exemptions and deductions available under the old system. Initially optional, this regime became the default in 2023, requiring taxpayers to opt out if they wished to continue under the old structure. Despite the removal of many benefits, certain